Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.48 (
transcriptase
)
9,479
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A ddRT-PCR analysis was performed to detect cellular genes that are differentially expressed after influenza A virus (H1N1) infection of A549 cells. After ddRT-PCR, eight DNA fragments were identified.
PRPF8
, one of the cellular genes that were upregulated after virus infection, was further analyzed since it has previously been identified as a cellular factor required for influenza virus replication. The upregulation of
PRPF8
gene expression after viral infection was confirmed using real-time RT-PCR for mRNA detection and Western blot analysis for protein detection. Influenza A virus also upregulated the
PRPF8
promoter in a reporter assay. In addition to H1N1, influenza A virus H3N2 and influenza B virus could also activate
PRPF8
expression. Therefore, upregulation of
PRPF8
expression might be important for the replication of different influenza viruses. Indeed, overexpression of
PRPF8
gene enhanced virus production, while knockdown of expression of this gene reduced viral production significantly. To determine which viral protein could enhance
PRPF8
gene expression, individual viral genes were cloned and expressed. Among the different viral proteins, expression of either the viral NS1 or PB1 gene could upregulate the
PRPF8
expression. Our results from this study indicate that influenza A virus upregulates cellular
PRPF8
gene expression through viral NS1 and
PB1 proteins
to increase virus production.
...
PMID:Influenza A virus upregulates PRPF8 gene expression to increase virus production. 2811 Apr 26
The splicing of group II introns in vivo requires the assistance of a multifunctional intron encoded protein (IEP, or maturase). Each IEP is also a reverse-
transcriptase
enzyme that enables group II introns to behave as mobile genetic elements. During splicing or retro-transposition, each group II intron forms a tight, specific complex with its own encoded IEP, resulting in a highly reactive holoenzyme. This review focuses on the structural basis for IEP function, as revealed by recent crystal structures of an IEP reverse transcriptase domain and cryo-EM structures of an IEP-intron complex. These structures explain how the same IEP scaffold is utilized for intron recognition, splicing and reverse transcription, while providing a physical basis for understanding the evolutionary transformation of the IEP into the eukaryotic
splicing factor Prp8
.
...
PMID:The group II intron maturase: a reverse transcriptase and splicing factor go hand in hand. 2852 6